Literature DB >> 11030719

Evidence for VIP(1)/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the rat.

G E Boeckxstaens1, M Hollmann, S H Heisterkamp, P Robberecht, W J de Jonge, R M van Den Wijngaard, G N Tytgat, P J Blommaart.   

Abstract

We previously reported activation of an inhibitory adrenergic and a non-adrenergic non-cholinergic (NANC) pathway during abdominal surgery relaxing the rat gastric fundus. In the present study, we investigated the possible role of nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) in the NANC part of the surgery-induced fundic relaxation. The effect of the NO biosynthesis inhibitor N(G)-nitro-L-arginine (L-NOARG), the non-selective VIP receptor antagonist [D-p-Cl-Phe(6),Leu(17)]-VIP and the selective VIP(1) receptor antagonist [Acetyl-His(1),D-Phe(2),Lys(15),Arg(16), Leu(17)]-VIP was investigated on the non-adrenergic fundic relaxation induced by manipulation of the small intestine followed by resection of the caecum. Guanethidine partly reduced the manipulation-induced fundic relaxation. Addition of L-NOARG reduced this non-adrenergic component, whereas the non-selective VIP receptor antagonist had no significant effect. Combination of L-NOARG and the non-selective VIP antagonist however further reduced the relaxation to manipulation. The selective VIP(1) receptor antagonist reduced the mean and maximal relaxation induced by abdominal surgery in the presence of guanethidine. When combined with L-NOARG, the relaxation of the gastric fundus was almost completely abolished. The VIP(1) receptor antagonist alone had no significant effect on the mean and maximal relaxation, but enhanced recovery of fundic tone. In conclusion, as VIP(1) receptors are not present in the rat gastric fundus, these results suggest that the NANC inhibitory pathway activated during abdominal surgery involves VIP(1) receptors, most likely in the afferent limb. The inhibitory neurotransmitters released at the level of the gastric fundus smooth muscle are NO and a substance different from VIP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030719      PMCID: PMC1572383          DOI: 10.1038/sj.bjp.0703625

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Influence of VIP antiserum and VIP antagonists on the effect of VIP and of non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus.

Authors:  M D'Amato; F A De Beurme; R A Lefebvre
Journal:  Pharmacol Res Commun       Date:  1988-05

2.  Inhibition of gastrointestinal transit due to surgical trauma or peritoneal irritation is reduced in capsaicin-treated rats.

Authors:  P Holzer; I T Lippe; U Holzer-Petsche
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

3.  Activation of an adrenergic and vagally-mediated NANC pathway in surgery-induced fundic relaxation in the rat.

Authors:  G E Boeckxstaens; D P Hirsch; A Kodde; T M Moojen; A Blackshaw; G N Tytgat; P J Blommaart
Journal:  Neurogastroenterol Motil       Date:  1999-12       Impact factor: 3.598

4.  Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions.

Authors:  T B Usdin; T I Bonner; E Mezey
Journal:  Endocrinology       Date:  1994-12       Impact factor: 4.736

5.  Reflex suppression of gastric motility during laparotomy and gastroduodenal nociceptive stimulation.

Authors:  H Abrahamsson; H Glise; K Glise
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

6.  Reflex vagal inhibition of gastric motility by intestinal nociceptive stimulation in the cat.

Authors:  H Glise; H Abrahamsson
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

7.  Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve.

Authors:  J M Lundberg; T Hökfelt; J Kewenter; G Pettersson; H Ahlman; R Edin; A Dahlström; G Nilsson; L Terenius; K Uvnäs-Wallensten; S Said
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

8.  Involvement of alpha-1 and alpha-2 adrenoceptors in the postlaparotomy intestinal motor disturbances in the rat.

Authors:  A Sagrada; M J Fargeas; L Bueno
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

9.  Comparison of the effect of vasoactive intestinal polypeptide and non-adrenergic non-cholinergic neurone stimulation in the cat gastric fundus.

Authors:  M D'Amato; F A De Beurme; R A Lefebvre
Journal:  Eur J Pharmacol       Date:  1988-07-26       Impact factor: 4.432

10.  Reflex adrenergic inhibition of gastric motility by nociceptive intestinal stimulation and peritoneal irritation in the cat.

Authors:  H Glise; B O Lindahl; H Abrahamsson
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

View more
  3 in total

1.  The ICAM-1 antisense oligonucleotide ISIS-3082 prevents the development of postoperative ileus in mice.

Authors:  Frans O The; Wouter J de Jonge; Roel J Bennink; Rene M van den Wijngaard; Guy E Boeckxstaens
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

2.  Methylnaltrexone in the treatment of opioid-induced constipation.

Authors:  Beverley Greenwood-Van Meerveld; Kelly M Standifer
Journal:  Clin Exp Gastroenterol       Date:  2008-12-14

Review 3.  Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach.

Authors:  Dora Reglodi; Anita Illes; Balazs Opper; Eszter Schafer; Andrea Tamas; Gabriella Horvath
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-19       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.